Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Scancell Holdings's Enterprise Value is $269.58 Mil.
Scancell Holdings's EBIT for the trailing twelve months (TTM) ended in Oct. 2025 was $-8.50 Mil. Therefore, Scancell Holdings's EV-to-EBIT ratio for today is -31.73.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Scancell Holdings's Enterprise Value is $269.58 Mil.
Scancell Holdings's EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 was $-7.47 Mil. Therefore, Scancell Holdings's EV-to-EBITDA ratio for today is -36.09.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Scancell Holdings's Enterprise Value is $269.58 Mil.
Scancell Holdings's Revenue for the trailing twelve months (TTM) ended in Oct. 2025 was $6.19 Mil. Therefore, Scancell Holdings's EV-to-Revenue ratio for today is 43.54.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Scancell Holdings (OTCPK:SCNLF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Scancell Holdings's current Enterprise Value is $269.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's EBIT for the trailing twelve months (TTM) ended in Oct. 2025 was $-8.50 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Scancell Holdings's current Enterprise Value is $269.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 was $-7.47 Mil.
Scancell Holdings's current Enterprise Value is $269.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's Revenue for the trailing twelve months (TTM) ended in Oct. 2025 was $6.19 Mil.
Scancell Holdings's current Enterprise Value is $269.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2025 was $-11.52 Mil.
Scancell Holdings's current Enterprise Value is $269.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2025 was $-13.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scancell Holdings Enterprise Value Related Terms
Scancell Holdings Enterprise Value Historical Data
* Premium members only.
The historical data trend for Scancell Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SCNLF vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Scancell Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scancell Holdings Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Scancell Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Scancell Holdings's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Scancell Holdings's Enterprise Value for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scancell Holdings (SCNLF) has a Enterprise Value of $269.58 Mil as of Jun. 27, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Scancell Holdings and its competitors.
Is Scancell Holdings' Enterprise Value too high?
Scancell Holdings' current Enterprise Value is $269.58 Mil. Overall, Scancell Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scancell Holdings' Enterprise Value compare to VRTX and REGN?
Scancell Holdings' Enterprise Value of $269.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Scancell Holdings and its competitors. Scancell Holdings's current Enterprise Value is $269.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scancell Holdings stock overvalued right now?
Scancell Holdings (SCNLF) has a current Enterprise Value of $269.58 Mil. The current Enterprise Value is $269.58 Mil. Scancell Holdings' overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Scancell Holdings (SCNLF), the current Enterprise Value is $269.58 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.
20GF Score
Get the complete analysis for SCNLF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCNLF has been successfully added to your 
